Berenberg Bank restated their buy rating on shares of Craneware (LON:CRW – Free Report) in a research report sent to investors on Tuesday morning,Digital Look reports. The firm currently has a GBX 2,800 ($36.25) price objective on the stock.
Separately, Shore Capital restated a “buy” rating on shares of Craneware in a research note on Tuesday.
View Our Latest Stock Analysis on Craneware
Craneware Stock Performance
Craneware Company Profile
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
See Also
- Five stocks we like better than Craneware
- The Significance of Brokerage Rankings in Stock Selection
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- About the Markup Calculator
- Why Energy Transfer Belongs on Your Watchlist
- Quiet Period Expirations Explained
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.